Regulation of vascular endothelial growth factor receptor 2 trafficking and angiogenesis by Golgi localized t-SNARE syntaxin 6

Venkatraman Manickam, Ajit Tiwari, Jae Joon Jung, Resham Bhattacharya, Apollina Goel, Debabrata Mukhopadhyay, Amit Choudhury

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Vascular endothelial growth factor receptor 2 (VEGFR2) plays a key role in physiologic and pathologic angiogenesis. Plasma membrane (PM) levels of VEGFR2 are regulated by endocytosis and secretory transport through the Golgi apparatus. To date, the mechanism whereby the VEGFR2 traffics through the Golgi apparatus remains incompletely characterized. We show in human endothelial cells that binding of VEGF to the cell surface localized VEGFR2 stimulates exit of intracellular VEGFR2 from the Golgi apparatus. Brefeldin A treatment reduced the level of surface VEGFR2, confirming that VEGFR2 traffics through the Golgi apparatus en route to the PM. Mechanistically, we show that inhibition of syntaxin 6, a Golgi-localized target membrane-soluble N-ethylmaleimide attachment protein receptor (t-SNARE) protein, interferes with VEGFR2 trafficking to the PM and facilitates lysosomal degradation of the VEGFR2. In cell culture, inhibition of syntaxin 6 also reduced VEGF-induced cell proliferation, cell migration, and vascular tube formation. Furthermore, in a mouse ear model of angiogenesis, an inhibitory form of syntaxin 6 reduced VEGF-induced neovascularization and permeability. Our data demonstrate the importance of syntaxin 6 in the maintenance of cellular VEGFR2 levels, and suggest that the inhibitory form of syntaxin 6 has good potential as an antiangiogenic agent.

Original languageEnglish (US)
Pages (from-to)1425-1435
Number of pages11
JournalBlood
Volume117
Issue number4
DOIs
StatePublished - Jan 27 2011

Fingerprint

Qa-SNARE Proteins
Vascular Endothelial Growth Factor Receptor-2
Ethylmaleimide
Membranes
Golgi Apparatus
Proteins
Cell membranes
Vascular Endothelial Growth Factor A
Cell Membrane
Physiologic Neovascularization
Pathologic Neovascularization
Brefeldin A
Angiogenesis Inhibitors
Endothelial cells
Cell proliferation
Endocytosis
Cell culture
Cell Movement
Ear
Blood Vessels

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

Regulation of vascular endothelial growth factor receptor 2 trafficking and angiogenesis by Golgi localized t-SNARE syntaxin 6. / Manickam, Venkatraman; Tiwari, Ajit; Jung, Jae Joon; Bhattacharya, Resham; Goel, Apollina; Mukhopadhyay, Debabrata; Choudhury, Amit.

In: Blood, Vol. 117, No. 4, 27.01.2011, p. 1425-1435.

Research output: Contribution to journalArticle

Manickam, Venkatraman ; Tiwari, Ajit ; Jung, Jae Joon ; Bhattacharya, Resham ; Goel, Apollina ; Mukhopadhyay, Debabrata ; Choudhury, Amit. / Regulation of vascular endothelial growth factor receptor 2 trafficking and angiogenesis by Golgi localized t-SNARE syntaxin 6. In: Blood. 2011 ; Vol. 117, No. 4. pp. 1425-1435.
@article{00e1c6f9bf7a46b5b7a28d9ca3bc947e,
title = "Regulation of vascular endothelial growth factor receptor 2 trafficking and angiogenesis by Golgi localized t-SNARE syntaxin 6",
abstract = "Vascular endothelial growth factor receptor 2 (VEGFR2) plays a key role in physiologic and pathologic angiogenesis. Plasma membrane (PM) levels of VEGFR2 are regulated by endocytosis and secretory transport through the Golgi apparatus. To date, the mechanism whereby the VEGFR2 traffics through the Golgi apparatus remains incompletely characterized. We show in human endothelial cells that binding of VEGF to the cell surface localized VEGFR2 stimulates exit of intracellular VEGFR2 from the Golgi apparatus. Brefeldin A treatment reduced the level of surface VEGFR2, confirming that VEGFR2 traffics through the Golgi apparatus en route to the PM. Mechanistically, we show that inhibition of syntaxin 6, a Golgi-localized target membrane-soluble N-ethylmaleimide attachment protein receptor (t-SNARE) protein, interferes with VEGFR2 trafficking to the PM and facilitates lysosomal degradation of the VEGFR2. In cell culture, inhibition of syntaxin 6 also reduced VEGF-induced cell proliferation, cell migration, and vascular tube formation. Furthermore, in a mouse ear model of angiogenesis, an inhibitory form of syntaxin 6 reduced VEGF-induced neovascularization and permeability. Our data demonstrate the importance of syntaxin 6 in the maintenance of cellular VEGFR2 levels, and suggest that the inhibitory form of syntaxin 6 has good potential as an antiangiogenic agent.",
author = "Venkatraman Manickam and Ajit Tiwari and Jung, {Jae Joon} and Resham Bhattacharya and Apollina Goel and Debabrata Mukhopadhyay and Amit Choudhury",
year = "2011",
month = "1",
day = "27",
doi = "10.1182/blood-2010-06-291690",
language = "English (US)",
volume = "117",
pages = "1425--1435",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "4",

}

TY - JOUR

T1 - Regulation of vascular endothelial growth factor receptor 2 trafficking and angiogenesis by Golgi localized t-SNARE syntaxin 6

AU - Manickam, Venkatraman

AU - Tiwari, Ajit

AU - Jung, Jae Joon

AU - Bhattacharya, Resham

AU - Goel, Apollina

AU - Mukhopadhyay, Debabrata

AU - Choudhury, Amit

PY - 2011/1/27

Y1 - 2011/1/27

N2 - Vascular endothelial growth factor receptor 2 (VEGFR2) plays a key role in physiologic and pathologic angiogenesis. Plasma membrane (PM) levels of VEGFR2 are regulated by endocytosis and secretory transport through the Golgi apparatus. To date, the mechanism whereby the VEGFR2 traffics through the Golgi apparatus remains incompletely characterized. We show in human endothelial cells that binding of VEGF to the cell surface localized VEGFR2 stimulates exit of intracellular VEGFR2 from the Golgi apparatus. Brefeldin A treatment reduced the level of surface VEGFR2, confirming that VEGFR2 traffics through the Golgi apparatus en route to the PM. Mechanistically, we show that inhibition of syntaxin 6, a Golgi-localized target membrane-soluble N-ethylmaleimide attachment protein receptor (t-SNARE) protein, interferes with VEGFR2 trafficking to the PM and facilitates lysosomal degradation of the VEGFR2. In cell culture, inhibition of syntaxin 6 also reduced VEGF-induced cell proliferation, cell migration, and vascular tube formation. Furthermore, in a mouse ear model of angiogenesis, an inhibitory form of syntaxin 6 reduced VEGF-induced neovascularization and permeability. Our data demonstrate the importance of syntaxin 6 in the maintenance of cellular VEGFR2 levels, and suggest that the inhibitory form of syntaxin 6 has good potential as an antiangiogenic agent.

AB - Vascular endothelial growth factor receptor 2 (VEGFR2) plays a key role in physiologic and pathologic angiogenesis. Plasma membrane (PM) levels of VEGFR2 are regulated by endocytosis and secretory transport through the Golgi apparatus. To date, the mechanism whereby the VEGFR2 traffics through the Golgi apparatus remains incompletely characterized. We show in human endothelial cells that binding of VEGF to the cell surface localized VEGFR2 stimulates exit of intracellular VEGFR2 from the Golgi apparatus. Brefeldin A treatment reduced the level of surface VEGFR2, confirming that VEGFR2 traffics through the Golgi apparatus en route to the PM. Mechanistically, we show that inhibition of syntaxin 6, a Golgi-localized target membrane-soluble N-ethylmaleimide attachment protein receptor (t-SNARE) protein, interferes with VEGFR2 trafficking to the PM and facilitates lysosomal degradation of the VEGFR2. In cell culture, inhibition of syntaxin 6 also reduced VEGF-induced cell proliferation, cell migration, and vascular tube formation. Furthermore, in a mouse ear model of angiogenesis, an inhibitory form of syntaxin 6 reduced VEGF-induced neovascularization and permeability. Our data demonstrate the importance of syntaxin 6 in the maintenance of cellular VEGFR2 levels, and suggest that the inhibitory form of syntaxin 6 has good potential as an antiangiogenic agent.

UR - http://www.scopus.com/inward/record.url?scp=79251553130&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79251553130&partnerID=8YFLogxK

U2 - 10.1182/blood-2010-06-291690

DO - 10.1182/blood-2010-06-291690

M3 - Article

C2 - 21063020

AN - SCOPUS:79251553130

VL - 117

SP - 1425

EP - 1435

JO - Blood

JF - Blood

SN - 0006-4971

IS - 4

ER -